• Home
  • About Us
    • About ReNeuron
    • Board of Directors
    • Senior Management
    • Advisory Board
    • Working at ReNeuron
    • Patents
  • Exosomes
  • iPSC
  • Partnering
    • Existing Partnerships & Collaborations
  • News
  • Investors
    • Investor Centre
    • Corporate Governance
    • Share Price Information
    • Major Shareholdings
    • Advisors
    • Analyst Research
    • Financial Reports
    • General Meetings
    • Financial Calendar
    • Email alerts
    • RNS Notifications
    • Documents and Circulars
    • AIM Rule 26
    • Declarations
  • Contact
    • Contact Us
ReNeuron logo
ReNeuron logo
  • Home
  • About Us
    • About ReNeuron
    • Board of Directors
    • Senior Management
    • Advisory Board
    • Working at ReNeuron
    • Patents
  • Exosomes
  • iPSC
  • Partnering
    • Existing Partnerships & Collaborations
  • News
  • Investors
    • Investor Centre
    • Corporate Governance
    • Share Price Information
    • Major Shareholdings
    • Advisors
    • Analyst Research
    • Financial Reports
    • General Meetings
    • Financial Calendar
    • Email alerts
    • RNS Notifications
    • Documents and Circulars
    • AIM Rule 26
    • Declarations
  • Contact
    • Contact Us

The Stem Cell-based Exosome Company 

ReNeuron is developing the next generation of engineered Exosomes.  Utilising our stem cell-based technologies, targeting tissues of interest and delivering payloads of choice.

Click here to see latest Analyst Research

About ReNeuron

Partnering

Patents Read more

Latest News

View all

R&D Update

Result of AGM

Notice of Annual General Meeting

Posting of Annual Report & Accounts

Preliminary Results for the year ended 31 March 2023

Share Price

More details

7p 0.000p

at 23-09-2023 4:07:00

15 minute delayed share price from London Stock Exchange provided by Euroland.

Share Price

More details

7p 0.000p

at 23-09-2023 4:07:00

15 minute delayed share price from London Stock Exchange provided by Euroland.

Exosomes

Exosomes banner image Read more

iPSC

CTX cells for Critical Limb Ischaemia Read more

Investor Centre

Investor Centre banner image Read more

Subscribe here for our Press Releases:

The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: 

© ReNeuron Group plc 2023 All rights reserved

Website design by Carr Kamasa Design

  • Privacy Notice
  • Disclaimer